News - immatics biotechnologies

Filter

Current filters:

immatics biotechnologies

Popular Filters

Executive Q&A: Paul Higham, CEO of immatics

Executive Q&A: Paul Higham, CEO of immatics

27-05-2014

In an interview with The Pharma Letter, immatics chief executive Paul Higham discusses the company's…

BiotechnologyCancerGermanyHealth Medical Pharmaimmatics biotechnologiesImmunologyInterviewsMedicineOncologyVaccination

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

Roche and immatics ink mega-million cancer vaccine and immunotherapy deal

13-11-2013

Germany’s privately-held immatics biotechnologies GmbH and Swiss drug major Roche have entered into…

BiotechnologyIMA942immatics biotechnologiesImmunologicalsOncologyRocheVaccines

EU supports GAPVAC to develop new personalized cancer vaccines with 6 million euros

04-07-2013

A highly innovative project supported by a 6 million euros ($7.8 million) European Union Framework 7…

BioNTechBiotechnologyEuropeFinancialimmatics biotechnologiesOncologyPharmaceuticalResearch

Back to top